TRANSBUCCAL DELIVERY OF SPRAY DRIED LOVASTATIN FROM MUCOADHESIVE BUCCAL PATCHES AND IN VITRO CHARACTERIZATION
Objective: The aim of the present work was to develop and characterize mucoadhesive film of spray dried Lovastatin (LVS) for buccal delivery to enhance bioavailability.
Methods: Mucoadhesive films were prepared by solvent casting technique by using different polymers HPMCK4M, HPMC E5LV and chitosan. The successful patches were evaluated for film thickness, weight, content uniformity, surface pH, swelling index, folding endurance, ex-vivo residence time, ex-vivo bioadhesion test, in vitro drug release, ex-vivo drug permeation and stability study.
Results: The thickness of all prepared patches ranged from 0.21±0.07 to 1.5±0.39 mm, the weight of the film 89.10±0.6 to 128.57±0.3 mg, drug content 85.47±0.87 to 97.33±0.31%, surface pH 5.6±0.67 to 7.6±0.98, swelling index 23.0±4.1 to 76.5±3.6%, folding endurance 165±1.9 to 350±2.5 respectively. Ex-vivo residence time ranged from 2.2±0.08to 8.2±0.17 h and ex-vivo bioadhesive strength 30±0.64 to 66±0.43 g. The formulations with HPMC E5 shown short period of residence time and shows weak force of adhesion., which might be because of low viscosity of the polymer which resulted into weak adhesion. The percentage drug release and ex-vivo drug permeation was in the following descending order HPMC K4M>HPMC E5LV>chitosan. These results confirm the extension of drug release in case of ionic polymer chitosan. The kinetics data shows that drug release and permeation follows nonfiction diffusion. Accelerated stability data revealed that there is no significant change in drug content, in vitro drug release and ex-vivo permeation.
Conclusion: It can be concluded that mucoadhesive buccal patch is a promising dosage form to enhance the drug bioavailability by preventing first-pass metabolism thus providing better therapeutic efficacy.
2. Meher JG, Tarai M, Yadav NP, Pathak A, Mishra P, Yadav K. Development and characterization of cellulose-polymethacrylate mucoadhesive film for buccal delivery of carvedilol. Carbohydr Polym 2017;96:172-80.
3. K Chandra Sekhar, KVS Naidu, Y Vamshi Vishnu, Ramesh Gannu, V Kishan, Y Madhusudan Rao. Transbuccal delivery of chlorpheniramine maleate from mucoadhesive buccal patches. Drug Delivery 2008;15:185–91.
4. Castan H, Ruiz B, Morales M, Design. Development and characterisation of buccal bioadhesive films of doxepin for treatment of odontalgia. Drug Delivery 2017;22:869-76.
5. Tripathi KD. Essentials of medical pharmacology. 6th ed. Jaypee brothers medical publishers; 2010.
6. Patel RP, Patel MM. Physicochemical charecterization and dissolution study of solid dispersions of lovastatin with PEG 4000 and Polyvinylpyrrolidone K30. Pharm Dev Technol 2007;12:21-33.
7. Parfitt K. Lipid regulating drugs: lovastatin, Martindale. 32nd ed. The Pharmaceutical Press; 1999.
8. Gerald SB, KE Micheal, JK Lovastatin. Analytical profiles of drug substances and excipients.1st ed. Acadaemic Press; 1998.
9. Jagadale S, Hable A, Kuchekar B. Improvement of dissolution rate of chlorzoxazone by solid dispersion technique and development of buccal patch. J Appl Sol Chem Model 2013;2:145-57.
10. Hassan MA, Barakat NS, El-Badry M, Shehata SM. Formulation and in vitro and in vivo evaluation of naproxen mucoadhesive buccal patches for local effect. J Drug Delivery Sci Technol 2011;21:423-31.
11. Patel RP, Poddar SS. Deveopment and characterization of mucoadhesive buccal patches of salbutamol sulphate. Curr Drug Delivery 2009;6:140-4.
12. Magdy M, Nadia S, Sarah R. Development of a novel ketorolac tromethamine sublingual film. J Am Sci 2015;11:27-37.
13. Cui F, Chunbai H, Miao H, Cui Tang, Lichen Y, Feng Q. Preperation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin. J Biomed Mater Res 2008;89:1063-71.
This work is licensed under a Creative Commons Attribution 4.0 International License.